NRBP2 and breast carcinoma: Zhiyu Li et al. have characterized NRBP2 overexpressing in breast cancer, revealing that such overexpression significantly inhibited cell proliferation and invasion, and inhibited epithelial-mesenchymal transition in cells in vitro.